Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) can be used to identify bacteria directly from positive blood and sterile fluid cultures. The authors evaluated a commercially available kit -the Sepsityper Kit (Bruker Daltonik, Germany) -and MALDI-TOF MS for the rapid identification of organisms from 80 flagged positive blood culture broths, of which 73 (91.2%) were blood culture specimens and seven (8.7%) were cerebrospinal fluid specimens, in comparison with conventional identification methods. Correct identification to the genus and species levels was obtained in 75 of 80 (93.8%) and 39 of 50 (78%) blood culture broths, respectively. Applying the blood culture analysis module, a newly developed software tool, improved the species identification of Gramnegative organisms from 94.7% to 100% and of Gram-positive organisms from 66.7% to 70%. MALDI-TOF MS is a promising tool for the direct identification of organisms cultured from sterile sites. loodstream and central nervous system infections are associated with high morbidity and mortality (1,2). With current diagnostic methods, final results are available often more than 72 h after sampling (3). Because outcome of septic patients has been shown to depend on the adequacy of early antimicrobial chemotherapy, crucial treatment decisions currently often rely on Gram-stain results from positive blood culture broths until identification can be determined following culture isolation (4). Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) enables the rapid identification to the species level of Gram-positive and Gramnegative bacteria, as well as yeasts, by comparing the spectra obtained from measuring molecular masses of proteins and other bacterial components obtained from whole organism extracts (5). A crude bacterial load of approximately 5×10 3 colony forming units is necessary for reliable MALDI-TOF analysis, suggesting that bacterial identification may be performed directly on positive blood culture pellets (6). We evaluated the Sepsityper Kit (Bruker Daltonik, Germany) for the rapid identification of organisms from flagged positive blood culture broths. The Sepsityper Kit is a commercially available kit used for preparing cells directly from positive blood culture broths.
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METhODS
Seventy-three blood culture specimens and seven cerebrospinal fluid (CSF) specimens submitted to the laboratory between February and May of 2011 were prospectively analyzed using the Bruker MALDI-TOF MS and Sepsityper Kit for the direct detection of organisms and compared with standard phenotypic identification methods. Blood was inoculated into BD BACTEC Standard 10/Aerobic F, BD BACTEC Standard Anaerobic/F or BD BACTEC Peds Plus/F (Becton Dickinson, USA) bottles at the bedside. CSF specimens received at the microbiology laboratory were inoculated into BD BACTEC Peds Plus/F bottles for enrichment. Blood culture broths were incubated in the BD BACTEC FX instrument (Becton Dickinson, USA). All BACTEC blood culture bottles are charcoal free.
Conventional identification methods
Gram stains were performed on positive blood culture broths before subculture on sheep blood, horse blood, chocolate and MacConkey agars (Oxoid, Canada), as appropriate, and incubated at 37°C in CO 2 for 18 h to 24 h, and anaerobically for 48 h. Isolates were then identified using the Phoenix automated microbiology system (BD Diagnostic Systems, USA). Gram-positive cocci resembling staphylococci on Gram stain were subjected to the tube coagulase test (rabbit plasma, BD BBL; Becton Dickinson, USA), and staphylococcal isolates were tested using the staphylococcal latex agglutination test (Pastorex; BioRad, USA). Gram-positive cocci arranged in pairs or chains were subcultured on blood agar with optochin disk, bile esculin agar and chocolate agar, and further biochemical tests were selected according to growth on the different plates based on standard protocols (7). For Gram-negative bacilli, subculture on CHROM Orientation agar (BD BBL; Becton Dickinson, USA), blood and MacConkey agars was performed. When identification using the Phoenix system was inconclusive or suspected to be incorrect, phenotypic identification of isolates was performed using API (bioMérieux, France). For cases in which all available phenotypic tests were inconclusive, amplification of the 16S DNA gene was performed followed by sequencing, or the specimen was sent to the provincial Public Health Laboratory (Ontario) for identification (8, 9) .
OrIgInAL ArTICLE

MALDI Sepsityper Kit
The kit was used according to the manufacturer's instructions. Briefly, 200 µL of lysis buffer was added to 1 mL of positive blood culture fluid in a reaction tube. The tube was vortexed for 10 s before centrifugation at 13,000 rpm for 1 min. The supernatant was then discarded, and the pellet was suspended in 1 mL of washing buffer and recentrifuged at 13,000 rpm for 1 min. The supernatant was discarded once more, the pellet was resuspended in 300 µL of deionized water and 900 µL of ethanol was added.
Ethanol/formic acid extraction
The suspension obtained following sample preparation as described above was centrifuged at 13,000 rpm for 2 min, and the supernatant discarded. The pellet was centrifuged for an additional 2 min before removal of residual ethanol. Sequentially, 50 µL each of formic acid (70% v/v) and 100% acetonitrile was added to the pellet (or less depending on pellet size) and thoroughly mixed after each reagent was added. The resuspension was centrifuged again at 13,000 rpm for an additional 2 min, and 1 µL of the supernatant was spotted onto the steel target plate. Analysis was performed following air-drying of 1 µL alpha-cyano-4-hydroxycinnamic acid matrix solution placed onto the dried sample spot in duplicate.
MS fingerprinting
Mass spectra were generated using the Microflex LT MS system operated by the MALDI-Biotyper automation control (Bruker Daltonik, Germany).
The degree of spectral concordance is expressed as a logarithmic identification score and interpreted by Biotyper software, version 2.0 (Bruker Daltonik). Scores ≥2.300 indicated species identification with a high level of confidence, ≥2.000 indicated species identification, 1.700 to 1.999 indicated genus identification, and <1.700 indicated no identification (10, 11) . Recently, the manufacturer has developed a new software tool, the MALDI Biotyper 3.1 software with Blood Culture Update v. 3.1.0.4 for the analysis of blood culture spectra that uses a lower cut-off value (Bruker Daltonik, personal communication). The spectra were reanalyzed using this newly developed blood culture analysis module and concordance of each software version was compared with conventional methods. This expanded database also includes updates such as increased spectra for analysis.
RESuLTS
Eighty positive blood culture broths were identified by the BACTEC FX automated blood culture system, of which 73 (91.2%) were blood culture specimens and seven (8.7%) were CSF specimens. Seventy specimens (87.5%) were monomicrobial and 10 (12.5%) were poly-microbial. Correct identification to the genus and species level was obtained in 75 of 80 (93.8%) and 39 of 50 (78%) blood culture broths, respectively. Gram-negative organisms (Table 1) were identified correctly to the genus level in 18 of 19 (94.7%) and to the species level in 18 of 19 (94.7%) specimens. Gram-positive organisms (Table 2) were identified correctly to the genus level in 56 of 60 (93.3%) and to the species 
.4. Conventional identification does not allow identification to the species level; § Conventional identification limited to catalase test and bacitracin disk. MALDI-TOF MS Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
level in 20 of 30 (66.7%) specimens. There were more Gram-negative organisms correctly identified to the species level than Gram-positive organisms (95% CI 0.01 to 0.9; P=0.03). Applying the blood culture analysis module, 100% of Gram-negative organisms were correctly identified to the species level, and 91.7% and 70% of Gram-positive organisms were identified to genus and species levels, respectively. Thirty-nine organisms had scores ≥2 (48.8%), 23 (28.8%) had scores between 1.7 and 1.99, 10 (12.5%) had scores of between 1.69 and 1.5, and seven (8.8%) had scores <1.5.
In each polymicrobial specimen, only one organism was successfully identified (Table 3) . One candidemia specimen was correctly identified as Candida parapsilosis, with a score of 1.98.
DISCuSSIOn
MALDI-TOF MS has significant potential for identifying organisms quickly and reliably from sterile body sites. Reported concordance rates between MALDI-TOF MS and conventional phenotypic methods for the direct identification of bacteria in non-charcoal-containing blood culture vials vary between 64.8% and 97% at the genus level, and 31.8% and 91.1% at the species level (10). Our study showed similar results, with overall concordance of 93.8% and 78% for genus and species levels, respectively. We also found some superiority in identification of Gram-negative organisms over Gram-positive organisms, which was also reported by Sogawa et al (11), Kok et al (12) and Vlek et al (13) . Juiz et al (14) reported better scores using the Sepsityper Kit for extraction of Gram-positive bacteria compared with an in-house extraction method.
Despite the reliability and short turnaround time for identification of organisms directly from specimens, our study revealed a number of shortcomings of MALDI-TOF MS. First, identification of viridans group streptococci to the species level occurred in only 38.4% of the specimens that contained this organism; seven isolates were misidentified as Streptococcus pneumoniae (Table 4) . Applying the blood culture analysis module, five viridans group streptococci isolates were misidentified as S pneumoniae. Misidentification of members of viridans group streptococci as S pneumoniae by MALDI-TOF MS was also reported by Kok et al (12) . Biochemical tests, such as optochin susceptibility and bile solubility, can be used to differentiate Streptococcus oralis and Streptococcus mitis from S pneumoniae isolates. Some authors have used a combination of MALDI-TOF and rapid antigen testing to achieve rapid identification of S pneumoniae (15) . Also, Warnero et al (16) found that it was possible to distinguish different species of the Mitis group streptococci by close analysis of their mass peak profiles. The technology is also not able to discriminate between Escherichia coli and Shigella species (17); however, this may be of less clinical relevance in our study because isolation of Shigella species from blood cultures and sterile sites is exceedingly rare. Third, in our study, one organism was misidentified as Pasteurella bettayae, with a score of 2.2; final genotypic identification proved the organism was a Pseudomonas species. This error was probably due to lack of reference spectra for variants of some species in the MALDI-Biotyper 2.0 application software. This organism was correctly identified as a Pseudomonas species on reanalysis of its spectra using the MALDI Biotyper 3.1 software with Blood Culture Update v. 3.1.0.4. Finally, MALDI-TOF MS was only able to identify one organism in each polymicrobial specimen, which was also reported by Ferroni et al (15) . However, polymicrobial bacteremia and sterile body site infections are relatively uncommon. The company is also currently working on software to analyze mixed specimens, which may assist in identifications in the future (Bruker Daltonik, personal communication).
There are several limitations to our study. The number of specimens included in the study was only a fraction of the number of actual specimens processed during the study period. This was due to the fact that the specimens were only processed on weekdays when the author was present at the microbiology laboratory. The main strength of our study is that it represents one of the first studies for direct identification of organisms from sterile body sites in a pediatric Canadian patient population.
COnCLuSIOnS
MALDI-TOF MS is a promising tool for the direct identification of organisms from sterile body sites; its reliability and rapid turnaround time can likely improve patients' outcomes. Software library development will likely overcome most of the identification limitations.
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